Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-11-15
2005-11-15
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S015800, C514S016700, C530S326000, C530S327000, C530S328000
Reexamination Certificate
active
06964948
ABSTRACT:
The present invention relates generally to small peptide-based constructs, including derivatized constructs, and their therapeutic uses. The constructs and derivatized constructs can have at least one of heparin binding, heparin neutralizing, endothelial cell proliferation inhibiting, antiangiogenic, LPS binding, LPS neutralization, or antimicrobial properties. The sequences of these constructs are based on a reverse subsequence derived from Domain II of bactericidal/permeability-increasing protein (BPI).
REFERENCES:
patent: 5639727 (1997-06-01), Little, II
patent: 6423825 (2002-07-01), Little, II et al.
patent: 6515104 (2003-02-01), Little, II et al.
patent: WO-97/04008 (1997-02-01), None
Lehninger et al., Biochemistry, 2d ed. (1993) pp. 112-116, 154-155.
Gikonyo J. G. Kinyua
Lin Jong-Jye
Little, II Roger G.
McAndrews Held & Malloy Ltd.
Russel Jeffrey Edwin
Xoma Technology Ltd.
LandOfFree
Therapeutic peptide-based constructs derived from Domain II... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic peptide-based constructs derived from Domain II..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic peptide-based constructs derived from Domain II... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3497457